APhA Medication Therapy Management (MTM) Certification Exam — Questions and Answers

Question 1: A pharmacist working in a collaborative practice agreement (CPA) that allows medication adjustments must document which of the following to remain compliant with both state law and MTM standards?

The pharmacist's personal opinion about the prescriber's original therapy choice
The CPA authority relied upon, clinical assessment, medication change made, and monitoring parameters (Correct answer)
The physician's signature obtained retroactively within 30 days
Only the final medication change, not the clinical rationale

Correct answer: The CPA authority relied upon, clinical assessment, medication change made, and monitoring parameters

CPA-based medication adjustments require documentation of the legal authority (the CPA), the clinical basis for the change, what was changed, and how the outcome will be monitored.

Question 2: A patient with stage 4 CKD (CrCl 20 mL/min) is started on enoxaparin for DVT treatment. What is the recommended dosing adjustment?

Reduce dose by 25%
No adjustment needed
Reduce dose to 1 mg/kg once daily (Correct answer)
Switch to unfractionated heparin only

Correct answer: Reduce dose to 1 mg/kg once daily

For CrCl < 30 mL/min, enoxaparin DVT treatment dose is reduced to 1 mg/kg subcutaneously once daily.

Question 3: Which patient counseling point is MOST critical for a patient self-administering subcutaneous methotrexate at home for rheumatoid arthritis?

Refrigerate methotrexate in original vials and use within 24 hours of opening
Avoid all NSAIDs for 30 days after each injection
Take folic acid supplementation daily to reduce mucositis and liver toxicity (Correct answer)
Inject methotrexate daily at the same time each day

Correct answer: Take folic acid supplementation daily to reduce mucositis and liver toxicity

Daily folic acid (1 mg) or folinic acid supplementation substantially reduces methotrexate-related toxicities including mucositis and elevated transaminases.

Question 4: A patient takes pantoprazole 40 mg daily at home. During hospitalization, they were switched to famotidine 20 mg BID (formulary substitution). At discharge, neither drug was listed. This scenario represents:

A complete omission of acid suppression therapy due to reconciliation failure (Correct answer)
A therapeutic duplication
Appropriate deprescribing of acid suppression therapy
An intentional switch back to the patient's home regimen

Correct answer: A complete omission of acid suppression therapy due to reconciliation failure

Neither the home drug nor the inpatient substitute was included at discharge, creating a complete omission of an indicated therapy due to reconciliation failure.

Question 5: Which of the following BEST describes 'shared decision-making' in an MTM context?

The patient independently selects their medications based on online research
The patient and clinician collaborate, combining clinical evidence with patient preferences to reach a treatment decision (Correct answer)
The pharmacist decides the best medication regimen and informs the patient
The prescriber and pharmacist jointly select medications without patient input

Correct answer: The patient and clinician collaborate, combining clinical evidence with patient preferences to reach a treatment decision

Shared decision-making is a collaborative process where both clinical evidence and patient preferences are integrated into treatment choices.

Question 6: Why are peak and trough levels monitored for certain antibiotics?

To check patient hydration.
To determine medication color.
To optimize dosing and reduce toxicity (Correct answer)
To evaluate adherence only.

Correct answer: To optimize dosing and reduce toxicity

For certain antibiotics, such as aminoglycosides, monitoring peak and trough levels is critical due to their narrow therapeutic window and potential for toxicity. Peak levels ensure that the drug concentration is high enough to be effective against the infection. Trough levels ensure that the drug clears adequately from the body to prevent accumulation and associated toxicities, thereby optimizing dosing for individual patients and minimizing adverse effects.

Question 7: Under the MTM documentation framework, a 'follow-up plan' included in the CMR written summary must address which of the following?

The patient's next pharmacy refill date for each medication
The prescriber's next available appointment slot
The plan sponsor's next annual enrollment period
Scheduled follow-up interactions and criteria for re-evaluation of drug therapy problems (Correct answer)

Correct answer: Scheduled follow-up interactions and criteria for re-evaluation of drug therapy problems

CMS guidance requires the CMR written summary to include a follow-up plan specifying when and under what circumstances the patient should be re-evaluated for identified drug therapy problems.

Question 8: Which metric is MOST commonly used to evaluate the effectiveness of care transition programs?

30-day hospital readmission rates (Correct answer)
Patient satisfaction scores only
Average length of hospital stay
Number of prescriptions filled post-discharge

Correct answer: 30-day hospital readmission rates

30-day readmission rates are the primary outcome measure for care transition interventions and are tied to CMS reimbursement penalties.

Question 9: When conducting a brown-bag review during a CMR, which item should the pharmacist ask the patient to bring?

Only prescription medications from the past 30 days
All prescription medications, OTC drugs, vitamins, herbals, and supplements (Correct answer)
Only medications prescribed by the primary care physician
Medications costing over $50/month only

Correct answer: All prescription medications, OTC drugs, vitamins, herbals, and supplements

A brown-bag review is only comprehensive when it includes ALL medications: Rx, OTC, vitamins, herbals, and dietary supplements.

Question 10: During an MTM session, a patient on dabigatran reports taking an over-the-counter proton pump inhibitor. What counseling point is most relevant?

The combination is absolutely contraindicated
PPIs have no interaction with dabigatran
PPIs reduce dabigatran bioavailability by increasing gastric pH (Correct answer)
PPIs increase dabigatran levels and worsen GI bleeding risk

Correct answer: PPIs reduce dabigatran bioavailability by increasing gastric pH

Dabigatran is formulated as a prodrug requiring an acidic gastric environment; PPIs raise gastric pH and reduce dabigatran bioavailability by approximately 12–30%.

Question 11: A pharmacist receives a referral for a patient who takes NSAIDs chronically for osteoarthritis and is also prescribed antihypertensives, diuretics, and an anticoagulant. Which drug-related problem should be addressed FIRST?

The antihypertensive dose should be doubled to overcome NSAID-mediated blood pressure elevation
NSAIDs increase bleeding risk with anticoagulants and blunt antihypertensive and diuretic efficacy, making them inappropriate in this combination (Correct answer)
The diuretic should be discontinued to prevent dehydration
Anticoagulant monitoring frequency should be reduced to avoid inconveniencing the patient

Correct answer: NSAIDs increase bleeding risk with anticoagulants and blunt antihypertensive and diuretic efficacy, making them inappropriate in this combination

Chronic NSAID use is contraindicated with anticoagulants due to additive bleeding risk and interferes with antihypertensive and diuretic mechanisms, representing multiple concurrent drug-related problems.

Question 12: A woman with atrial fibrillation on anticoagulation discovers she is pregnant. Which anticoagulant is considered safest during the second trimester?

Warfarin
Apixaban
Low molecular weight heparin (LMWH) (Correct answer)
Dabigatran

Correct answer: Low molecular weight heparin (LMWH)

LMWH is preferred throughout pregnancy because it does not cross the placenta, unlike warfarin which is teratogenic, and DOACs which lack adequate safety data in pregnancy.

Question 13: What is the most effective way to measure success in behavioral health pharmacotherapy within MTM professional practice?

Compare only with industry averages without considering context
Use a combination of quantitative metrics, qualitative assessments, and stakeholder feedback aligned with defined objectives (Correct answer)
Count only the number of activities completed
Rely solely on supervisor opinion

Correct answer: Use a combination of quantitative metrics, qualitative assessments, and stakeholder feedback aligned with defined objectives

Effective measurement combines multiple data sources — quantitative metrics, qualitative assessments, and stakeholder feedback — all aligned with clearly defined objectives for a comprehensive evaluation.

Question 14: A patient's Personal Medication Record (PMR) generated after a CMR should include which of the following?

Pharmacy profit margins for each drug
The prescriber's DEA number for controlled substances
Patient allergies, all current medications with doses and indications, and OTC/supplements (Correct answer)
Only the three most recently added medications

Correct answer: Patient allergies, all current medications with doses and indications, and OTC/supplements

The PMR is a comprehensive patient-held record including allergies, all medications (Rx, OTC, supplements) with dosing and indications.

Question 15: According to GINA guidelines, what is the preferred first-line controller therapy for mild persistent asthma in adults?

Inhaled corticosteroid (ICS) (Correct answer)
Short-acting beta-agonist (SABA) as needed only
Long-acting beta-agonist (LABA) alone
Oral leukotriene receptor antagonist (LTRA)

Correct answer: Inhaled corticosteroid (ICS)

Inhaled corticosteroids are the preferred first-line controller for persistent asthma due to superior anti-inflammatory efficacy over all other options.

Question 16: A patient with type 2 diabetes has an A1C of 9.2% on metformin monotherapy. Which add-on agent provides the greatest A1C reduction while minimizing hypoglycemia risk?

Glipizide
Pioglitazone
Semaglutide (Correct answer)
Sitagliptin

Correct answer: Semaglutide

GLP-1 receptor agonists like semaglutide provide 1.5-2% A1C reduction with low hypoglycemia risk and additional cardiovascular benefits.

Question 17: A 72-year-old patient with hypertension, heart failure, and CKD stage 3 is taking lisinopril 40 mg, spironolactone 25 mg, and potassium chloride supplements. Which concern should the pharmacist prioritize?

Renal toxicity from ACE inhibitor use
Hyperkalemia risk from concurrent use of multiple potassium-retaining agents (Correct answer)
Inadequate diuresis in heart failure management
Hypotension from excessive antihypertensive therapy

Correct answer: Hyperkalemia risk from concurrent use of multiple potassium-retaining agents

Concurrent use of an ACE inhibitor, aldosterone antagonist, and potassium supplement significantly increases the risk of life-threatening hyperkalemia.

Question 18: A 65-year-old patient taking a statin, ACE inhibitor, beta-blocker, aspirin, diuretic, and two diabetes agents following an MI presents with new myalgia. Which medication is MOST likely responsible?

Aspirin causing anti-inflammatory rebound myalgia
Statin therapy causing drug-induced myopathy (Correct answer)
Beta-blocker causing peripheral muscle fatigue
ACE inhibitor causing musculoskeletal side effects

Correct answer: Statin therapy causing drug-induced myopathy

Statin-induced myopathy is a well-recognized adverse effect presenting as myalgia or elevated creatine kinase levels, particularly when combined with interacting medications.

Question 19: When monitoring a patient on amiodarone long-term, which organ system requires the MOST frequent surveillance due to potentially irreversible toxicity?

Pulmonary (chest X-ray annually)
Kidneys (serum creatinine every 3 months)
Liver (LFTs every 6 months)
Thyroid (TFTs every 6 months) (Correct answer)

Correct answer: Thyroid (TFTs every 6 months)

Amiodarone contains 37% iodine by weight and causes thyroid dysfunction in up to 14% of patients, requiring TFT monitoring every 6 months.

Question 20: A pharmacist providing MTM for a patient on oral posaconazole suspension for prophylaxis notes it is being administered without food. What is the clinical significance?

Food has no effect on posaconazole suspension absorption
Posaconazole suspension must be taken on an empty stomach to prevent GI upset
Only the delayed-release tablet requires food for optimal absorption
Food, especially high-fat meals, significantly increases posaconazole suspension bioavailability; without food, plasma levels may be subtherapeutic (Correct answer)

Correct answer: Food, especially high-fat meals, significantly increases posaconazole suspension bioavailability; without food, plasma levels may be subtherapeutic

Posaconazole oral suspension requires administration with food (preferably high-fat meal) or a nutritional supplement to achieve adequate therapeutic plasma levels.

Question 21: Which second-generation antipsychotic is associated with the lowest risk of metabolic syndrome (weight gain, dyslipidemia, hyperglycemia)?

Quetiapine
Clozapine
Olanzapine
Aripiprazole (Correct answer)

Correct answer: Aripiprazole

Aripiprazole (and ziprasidone) have the most favorable metabolic profiles among SGAs, with minimal effects on weight, lipids, and glucose compared to olanzapine and clozapine.

Question 22: Which parameter requires routine monitoring when a patient is maintained on long-term nintedanib (Ofev) for idiopathic pulmonary fibrosis?

24-hour urine creatinine
Serum uric acid
INR monthly
Liver function tests (ALT/AST) monthly for the first 3 months, then periodically thereafter (Correct answer)

Correct answer: Liver function tests (ALT/AST) monthly for the first 3 months, then periodically thereafter

Nintedanib is associated with hepatotoxicity and requires liver function monitoring monthly for the first 3 months, then periodically, with dose modification if elevated.

Question 23: Dabigatran is contraindicated in patients with CrCl below what threshold due to risk of bleeding?

30 mL/min (Correct answer)
60 mL/min
15 mL/min
45 mL/min

Correct answer: 30 mL/min

Dabigatran is contraindicated when CrCl < 30 mL/min because 80% is renally eliminated, leading to dangerous drug accumulation.

Question 24: A patient's CMR reveals she takes levothyroxine with calcium supplements simultaneously each morning. What optimization is indicated?

No change needed; interaction is not clinically significant
Discontinue calcium supplementation
Switch levothyroxine to evening dosing only
Separate levothyroxine and calcium by at least 4 hours (Correct answer)

Correct answer: Separate levothyroxine and calcium by at least 4 hours

Calcium significantly reduces levothyroxine absorption; separating administration by at least 4 hours prevents this interaction.

Question 25: When a MTM professional encounters an unfamiliar challenge in behavioral health pharmacotherapy, what is the recommended first course of action?

Proceed based on personal intuition alone
Research applicable standards, consult with subject matter experts, and document the approach (Correct answer)
Apply the solution used for the most recent similar problem without adaptation
Postpone addressing the issue indefinitely

Correct answer: Research applicable standards, consult with subject matter experts, and document the approach

Professional practice requires a methodical approach to unfamiliar challenges: research the applicable standards, consult experts when needed, and document the reasoning for the chosen approach.

Question 26: What role does continuous improvement play in anticoagulation management for MTM certified professionals?

It focuses exclusively on cost reduction
It applies only to new professionals in their first year
It is optional and only necessary during certification renewal
It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation (Correct answer)

Correct answer: It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation

Continuous improvement is fundamental to professional practice in anticoagulation management, involving regular evaluation, feedback integration, and process enhancement to maintain high standards.

Question 27: A patient with T2DM on insulin detemir develops recurrent fasting hyperglycemia despite titration. The pharmacist suspects dawn phenomenon. Which adjustment is most appropriate?

Administer insulin detemir at bedtime instead of morning (Correct answer)
Add a mealtime rapid-acting insulin at breakfast
Add metformin to suppress hepatic glucose output overnight
Switch to premixed insulin 70/30

Correct answer: Administer insulin detemir at bedtime instead of morning

Administering basal insulin at bedtime targets the overnight rise in glucose from the dawn phenomenon more effectively than morning dosing.

Question 28: Which combination inhaler is most appropriate as initial maintenance therapy for a COPD patient classified as GOLD Group B?

LABA/LAMA combination (Correct answer)
LAMA monotherapy
ICS alone
Triple therapy with ICS/LABA/LAMA

Correct answer: LABA/LAMA combination

GOLD guidelines recommend LABA/LAMA combination as preferred initial maintenance for Group B patients due to superior bronchodilation over monotherapy.

Question 29: In electronic health record (EHR) integration for MTM, which documentation practice best supports interoperability with prescribers' systems?

Using proprietary pharmacy software codes exclusive to the MTM platform
Limiting documentation to free-text narratives without coded data elements
Scanning handwritten notes as unstructured image files
Documenting clinical findings and recommendations using standardized terminologies such as SNOMED CT or RxNorm (Correct answer)

Correct answer: Documenting clinical findings and recommendations using standardized terminologies such as SNOMED CT or RxNorm

Using standardized terminologies like SNOMED CT for diagnoses and RxNorm for medications enables structured data exchange between pharmacy and prescriber EHR systems.

Question 30: During a comprehensive medication review, a pharmacist identifies that a patient is taking a PPI, an H2 blocker, and antacids simultaneously. This situation BEST represents which polypharmacy concern?

Drug-drug interaction
Subtherapeutic dosing
Inappropriate indication
Therapeutic duplication (Correct answer)

Correct answer: Therapeutic duplication

Using multiple agents from the same therapeutic class (PPI, H2 blocker, antacids) for the same indication constitutes therapeutic duplication.

Question 31: Which of the following is a key element of an opioid treatment agreement (pain management agreement) that an MTM pharmacist should review with a patient?

Agreement that the patient will not discuss pain management with other providers
Expectations regarding urine drug testing, single pharmacy use, and safe storage of medications (Correct answer)
Waiver of the patient's right to request medication changes
Guarantee that opioid therapy will continue indefinitely as long as the patient is compliant

Correct answer: Expectations regarding urine drug testing, single pharmacy use, and safe storage of medications

Opioid treatment agreements outline patient responsibilities including urine drug testing, using a single prescriber and pharmacy, safe storage, and not sharing medications.

Question 32: Which monitoring parameter is MOST critical when initiating sacubitril/valsartan (Entresto) in a heart failure patient already on an ACE inhibitor?

Liver function tests
Blood glucose
Serum potassium and renal function after a 36-hour washout period (Correct answer)
Complete blood count

Correct answer: Serum potassium and renal function after a 36-hour washout period

A 36-hour washout of ACE inhibitors is required before starting sacubitril/valsartan to prevent life-threatening angioedema due to bradykinin accumulation.

Question 33: A patient develops tardive dyskinesia after years of haloperidol use. Which medication is FDA-approved to treat this movement disorder?

Diphenhydramine
Propranolol
Valbenazine (Correct answer)
Benztropine

Correct answer: Valbenazine

Valbenazine (Ingrezza) and deutetrabenazine are FDA-approved VMAT2 inhibitors indicated for the treatment of tardive dyskinesia.

Question 34: A pharmacist practicing patient-centered care should primarily base treatment recommendations on:

What the prescribing physician has already ordered
Current clinical guidelines without deviation
The most cost-effective drug regardless of patient preferences
The patient's values, preferences, and individual clinical circumstances (Correct answer)

Correct answer: The patient's values, preferences, and individual clinical circumstances

Patient-centered care integrates the patient's values, preferences, and individual circumstances alongside clinical evidence.

Question 35: A pharmacist submits an MTM claim using CPT code 99605. This code is most appropriately used for:

Group MTM education sessions with four or more patients
An initial MTM service with a new patient, face-to-face, up to 15 minutes (Correct answer)
A follow-up MTM service with an established patient, 15 minutes
A telephone-based TMR of any duration

Correct answer: An initial MTM service with a new patient, face-to-face, up to 15 minutes

CPT 99605 is designated for an initial MTM encounter with a new patient, face-to-face, for up to 15 minutes, and is distinct from follow-up or telephone-based service codes.

Question 36: How should pharmacists respond to non-adherence issues?

Discuss barriers and offer support (Correct answer)
Blame the patient
Increase medication dosage
Dismiss the concern

Correct answer: Discuss barriers and offer support

Non-adherence is often a complex issue stemming from various barriers like cost, side effects, misunderstanding, or forgetfulness, rather than a patient's unwillingness. Pharmacists should approach non-adherence with a supportive, non-judgmental attitude, actively listening to identify these specific barriers. By discussing these challenges and offering practical solutions and support, pharmacists can help patients overcome obstacles and improve their medication adherence.

Question 37: A pharmacist is performing MTM for a patient with CrCl of 40 mL/min taking rivaroxaban 20 mg daily for atrial fibrillation. What recommendation is appropriate?

Discontinue rivaroxaban; it is contraindicated below CrCl 50 mL/min
Reduce to 15 mg daily with the evening meal (Correct answer)
Switch to rivaroxaban 10 mg daily
Continue current regimen; no adjustment needed at this CrCl

Correct answer: Reduce to 15 mg daily with the evening meal

For non-valvular AF patients with CrCl 15–50 mL/min, rivaroxaban should be reduced to 15 mg once daily with the evening meal.

Question 38: A patient with COPD and atrial fibrillation is prescribed theophylline. Which newly added medication would MOST increase the risk of theophylline toxicity?

Prednisone
Tiotropium
Ciprofloxacin (Correct answer)
Albuterol inhaler

Correct answer: Ciprofloxacin

Ciprofloxacin is a potent CYP1A2 inhibitor that can increase theophylline concentrations by 30-50%, leading to toxicity including seizures and arrhythmias.

Question 39: A pharmacist uses the STOPP/START criteria during an MTM encounter. What does the START component specifically identify?

Medications requiring therapeutic drug monitoring
Medications that should be stopped immediately
Medications that should be initiated but are being withheld inappropriately (Correct answer)
Drugs with the highest risk of adverse effects

Correct answer: Medications that should be initiated but are being withheld inappropriately

The START (Screening Tool to Alert to Right Treatment) component identifies evidence-based medications that are indicated but not being prescribed.

Question 40: In the context of MTM certification, what is the most important consideration when implementing transitions of care & reconciliation?

Minimizing documentation to save time
Delegating all responsibilities to junior staff
Completing implementation as quickly as possible regardless of quality
Ensuring alignment with established standards, stakeholder needs, and best practices (Correct answer)

Correct answer: Ensuring alignment with established standards, stakeholder needs, and best practices

When implementing transitions of care & reconciliation, MTM professionals must ensure alignment with industry standards and stakeholder needs. Hasty implementation without proper planning often leads to compliance issues and suboptimal outcomes.

Question 41: What role does continuous improvement play in diabetes & cardiovascular pharmacotherapy for MTM certified professionals?

It is optional and only necessary during certification renewal
It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation (Correct answer)
It applies only to new professionals in their first year
It focuses exclusively on cost reduction

Correct answer: It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation

Continuous improvement is fundamental to professional practice in diabetes & cardiovascular pharmacotherapy, involving regular evaluation, feedback integration, and process enhancement to maintain high standards.

Question 42: Which laboratory finding most urgently warrants discontinuation of an ACE inhibitor?

Serum potassium of 5.5 mEq/L
Persistent dry cough for 2 weeks
Serum potassium of 6.5 mEq/L with ECG changes (Correct answer)
Serum creatinine increase of 15% from baseline

Correct answer: Serum potassium of 6.5 mEq/L with ECG changes

Severe hyperkalemia (≥6.0 mEq/L) with ECG changes represents a life-threatening emergency requiring immediate ACE inhibitor discontinuation.

Question 43: A patient is discharged from the hospital on warfarin 5 mg daily, but their outpatient record shows warfarin 2.5 mg daily. What is the pharmacist's FIRST action?

Ask the patient which dose they prefer
Dispense the higher dose as ordered by the hospital
Contact the discharging physician to clarify the intended dose (Correct answer)
Dispense the lower outpatient dose until the physician is available

Correct answer: Contact the discharging physician to clarify the intended dose

Dose discrepancies require immediate clarification with the prescriber before dispensing to prevent patient harm.

Question 44: When setting medication-related goals with a patient, the MTM pharmacist should ensure goals are SMART. What does the 'A' in SMART stand for?

Assessed
Automated
Achievable (Correct answer)
Accurate

Correct answer: Achievable

In SMART goal-setting, 'A' stands for Achievable, meaning the goal must be realistic given the patient's circumstances.

Question 45: A patient with opioid use disorder is started on buprenorphine/naloxone. When should the first dose be administered to avoid precipitated withdrawal?

Only after a confirmed negative urine drug screen
24 hours after last opioid use regardless of symptoms
Immediately after last opioid use
When the patient is in mild-to-moderate withdrawal (COWS score ≥8) (Correct answer)

Correct answer: When the patient is in mild-to-moderate withdrawal (COWS score ≥8)

Buprenorphine should be initiated when the patient is in mild-to-moderate withdrawal (COWS ≥8) to prevent precipitated withdrawal caused by buprenorphine's high opioid receptor affinity displacing full agonists.

Question 46: A pharmacist conducting an MTM encounter discovers a patient is using a medication not covered by their Part D plan. How should this be documented in the MAP?

Flag it as an illicit medication use
List it under the patient's complete medication list with notation of payment source (Correct answer)
Only document it if it causes a drug interaction
Omit it since it is not a covered Part D medication

Correct answer: List it under the patient's complete medication list with notation of payment source

The Medication Action Plan should reflect all medications the patient uses regardless of coverage status, with notation of cash-pay or other payer source.

Question 47: How should MTM professionals handle confidential information related to anticoagulation management?

Share freely with all colleagues for transparency
Follow established protocols for data protection, access control, and disclosure in accordance with applicable regulations (Correct answer)
Store information without any security measures
Delete all records after project completion

Correct answer: Follow established protocols for data protection, access control, and disclosure in accordance with applicable regulations

Confidential information must be handled according to established protocols, regulatory requirements, and professional ethics standards, including proper access control and disclosure procedures.

Question 48: A pharmacist is developing a transitions of care program for patients with heart failure. Which intervention has the STRONGEST evidence for reducing 30-day readmissions?

Sending a written letter to the patient's cardiologist only
Providing a phone-based follow-up call within 72 hours of discharge combined with a medication review (Correct answer)
Scheduling a follow-up appointment at 30 days post-discharge
Mailing a medication list to the patient's home

Correct answer: Providing a phone-based follow-up call within 72 hours of discharge combined with a medication review

Early phone follow-up combined with medication review within 72 hours of discharge has the strongest evidence base for reducing heart failure readmissions.

Question 49: How long should pharmacy records be retained according to federal regulations?

Indefinitely without review.
2–10 years, depending on law and record type (Correct answer)
1 month.
1 year.

Correct answer: 2–10 years, depending on law and record type

The retention period for pharmacy records varies, typically ranging from 2 to 10 years, depending on specific federal and state laws and the type of record. These varying requirements ensure that records are available for audits, legal proceedings, and continuity of patient care for a sufficient duration, balancing accessibility with storage practicalities.

Question 50: Which schedule classification does the DEA assign to hydrocodone combination products (e.g., Vicodin) as of 2014?

Schedule III
Schedule IV
Schedule II (Correct answer)
Schedule V

Correct answer: Schedule II

In 2014, the DEA reclassified hydrocodone combination products from Schedule III to Schedule II due to high abuse potential, requiring a written prescription with no refills.

Question 51: Which of the following is an absolute contraindication to the use of GLP-1 receptor agonists?

Personal or family history of medullary thyroid carcinoma (Correct answer)
Mild to moderate renal impairment
Obesity with BMI > 35 kg/m²
History of pancreatitis

Correct answer: Personal or family history of medullary thyroid carcinoma

GLP-1 receptor agonists carry a black box warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN2.

Question 52: A pharmacist performs MTM for a patient taking oxycodone and alprazolam. What is the primary concern with this combination?

Synergistic CNS and respiratory depression increasing overdose risk (Correct answer)
Increased risk of serotonin syndrome
Reduced opioid analgesic efficacy due to enzyme induction
Reduced benzodiazepine anxiolytic effect

Correct answer: Synergistic CNS and respiratory depression increasing overdose risk

Concurrent opioid and benzodiazepine use causes additive CNS and respiratory depression, substantially increasing the risk of fatal overdose.

Question 53: Why is accurate documentation crucial in pharmacy practice?

It improves product inventory only.
It supports care continuity and fulfills legal & regulatory requirements (Correct answer)
It eliminates the need for electronic health records.
It allows billing for more services.

Correct answer: It supports care continuity and fulfills legal & regulatory requirements

Accurate and comprehensive documentation in pharmacy practice is essential for several reasons. It ensures that all healthcare providers have access to a complete patient history, facilitating seamless transitions of care and preventing medication errors. Furthermore, it serves as a legal record, demonstrating compliance with professional standards and fulfilling regulatory requirements, thereby protecting both the patient and the practitioner.

Question 54: A patient with acute PE is found to have antiphospholipid syndrome (APS). Which anticoagulant strategy is preferred for long-term management?

Rivaroxaban 20 mg daily
Warfarin with target INR 2–3 (Correct answer)
Dabigatran 150 mg twice daily
Apixaban 5 mg twice daily

Correct answer: Warfarin with target INR 2–3

Warfarin remains the preferred anticoagulant for APS because DOACs have been associated with higher rates of arterial thromboembolism in this population.

Question 55: In an MTM consultation, a patient with T2DM reports taking ibuprofen daily for arthritis pain. What is the primary concern related to their cardiovascular medications?

NSAIDs can raise blood pressure and blunt the effect of antihypertensives (Correct answer)
NSAIDs cause hypoglycemia when combined with sulfonylureas
Ibuprofen increases the risk of lactic acidosis with metformin
Ibuprofen decreases effectiveness of insulin

Correct answer: NSAIDs can raise blood pressure and blunt the effect of antihypertensives

NSAIDs cause sodium retention and vasoconstriction, which can raise blood pressure and reduce the efficacy of antihypertensive medications.

Question 56: When a MTM professional encounters an unfamiliar challenge in polypharmacy assessment & reduction, what is the recommended first course of action?

Apply the solution used for the most recent similar problem without adaptation
Postpone addressing the issue indefinitely
Proceed based on personal intuition alone
Research applicable standards, consult with subject matter experts, and document the approach (Correct answer)

Correct answer: Research applicable standards, consult with subject matter experts, and document the approach

Professional practice requires a methodical approach to unfamiliar challenges: research the applicable standards, consult experts when needed, and document the reasoning for the chosen approach.

Question 57: A patient on warfarin is transitioning from hospital to home. The safest protocol includes all of the following EXCEPT:

Scheduling an INR check within 3-5 days of discharge
Educating the patient on signs of bleeding
Confirming the patient has access to their warfarin prescription
Automatically resuming the pre-hospitalization warfarin dose without assessment (Correct answer)

Correct answer: Automatically resuming the pre-hospitalization warfarin dose without assessment

Warfarin dosing post-hospitalization requires reassessment, not automatic resumption, because clinical factors may have changed during the hospital stay.

Question 58: Which documentation system is most commonly used in MTM practice?

FEMA.
ABC model.
SOAP (Correct answer)
IRS.

Correct answer: SOAP

The SOAP (Subjective, Objective, Assessment, Plan) documentation system is most commonly used in MTM practice because it provides a structured and comprehensive framework. This method allows pharmacists to systematically record patient information, clinical findings, their professional assessment of drug therapy problems, and a clear plan for intervention and follow-up, facilitating consistent and effective care.

Question 59: Which of the following best describes the mechanism by which SGLT2 inhibitors reduce hospitalizations for heart failure?

They inhibit aldosterone secretion decreasing fluid retention
They increase myocardial contractility by blocking sodium-calcium exchange
They reduce preload and afterload through osmotic diuresis and natriuresis (Correct answer)
They lower HbA1c which directly reduces cardiac workload

Correct answer: They reduce preload and afterload through osmotic diuresis and natriuresis

SGLT2 inhibitors reduce cardiac preload and afterload primarily through glucosuria-driven osmotic diuresis and sodium excretion, independent of glycemic effects.

Question 60: The prescribing information for a drug states 'reduce dose by 50% when CrCl is 30-60 mL/min.' A patient's estimated CrCl is 45 mL/min. What is this adjustment based on?

Pharmacodynamic studies
Phase III clinical trials only
Post-marketing surveillance data
Pharmacokinetic studies measuring drug exposure at different renal function levels (Correct answer)

Correct answer: Pharmacokinetic studies measuring drug exposure at different renal function levels

Renal dose adjustment recommendations derive from pharmacokinetic studies that measure AUC and clearance at varying levels of kidney function.

Question 61: Under CMS MTM program standards, which of the following patients would MOST likely meet eligibility criteria for enrollment?

A 68-year-old Medicare Part D enrollee with diabetes, heart failure, and COPD taking 9 chronic medications (Correct answer)
A 55-year-old with no chronic conditions taking antibiotics for an acute infection
A 45-year-old with a single chronic condition taking one medication
A 72-year-old taking two OTC supplements with no prescription drug coverage

Correct answer: A 68-year-old Medicare Part D enrollee with diabetes, heart failure, and COPD taking 9 chronic medications

CMS MTM eligibility typically requires multiple chronic conditions, multiple Part D medications, and likelihood of incurring high annual drug costs, which the 68-year-old clearly meets.

Question 62: Which specialty medication for hepatitis C requires genotype testing before prescribing to confirm efficacy?

Sofosbuvir/velpatasvir (Epclusa) — which covers all genotypes
Ledipasvir/sofosbuvir (Harvoni) — effective for genotypes 1, 4, 5, 6
Elbasvir/grazoprevir (Zepatier) — effective for genotypes 1 and 4 only (Correct answer)
Ribavirin

Correct answer: Elbasvir/grazoprevir (Zepatier) — effective for genotypes 1 and 4 only

Elbasvir/grazoprevir is indicated only for HCV genotypes 1 and 4, making genotype testing essential before prescribing.

Question 63: What role does continuous improvement play in transitions of care & reconciliation for MTM certified professionals?

It focuses exclusively on cost reduction
It applies only to new professionals in their first year
It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation (Correct answer)
It is optional and only necessary during certification renewal

Correct answer: It drives ongoing enhancement of practices, processes, and outcomes through systematic evaluation

Continuous improvement is fundamental to professional practice in transitions of care & reconciliation, involving regular evaluation, feedback integration, and process enhancement to maintain high standards.

Question 64: When a pharmacist identifies a potential drug-drug interaction during an MTM session and documents a recommendation to the prescriber, which element is most critical to include?

The patient's copay amount for each interacting drug
The clinical rationale and supporting evidence for the recommendation (Correct answer)
The pharmacy's NPI number
The patient's marital status

Correct answer: The clinical rationale and supporting evidence for the recommendation

Documentation of the clinical rationale and evidence base for a prescriber recommendation demonstrates professional judgment and supports continuity of care.

Question 65: What is the mechanism of action of tiotropium (Spiriva)?

Leukotriene receptor antagonism
Beta-2 receptor agonism
Phosphodiesterase-4 inhibition
Muscarinic receptor antagonism (Correct answer)

Correct answer: Muscarinic receptor antagonism

Tiotropium is a long-acting muscarinic antagonist (LAMA) that blocks M3 receptors in bronchial smooth muscle to produce sustained bronchodilation.

Question 66: Which of the following best describes a key competency required for polypharmacy assessment & reduction in MTM practice?

Strong analytical skills combined with effective communication and ethical judgment (Correct answer)
Memorization of all relevant regulations without understanding context
The ability to work independently without any oversight
Reliance on a single methodology for all situations

Correct answer: Strong analytical skills combined with effective communication and ethical judgment

MTM professionals working in polypharmacy assessment & reduction need analytical skills to assess situations, communication skills to convey findings, and ethical judgment to make sound decisions.

Question 67: During an MTM session, a patient on trastuzumab (Herceptin) for HER2-positive breast cancer asks about heart-related risks. What monitoring is standard?

Monthly ECG
Echocardiogram or MUGA scan at baseline and every 3 months during therapy (Correct answer)
Annual stress test
Serum troponin monthly

Correct answer: Echocardiogram or MUGA scan at baseline and every 3 months during therapy

Cardiac function (LVEF) must be assessed at baseline and every 3 months during trastuzumab therapy due to risk of cardiotoxicity.

Question 68: A patient on simvastatin 80 mg is newly prescribed amlodipine. What is the pharmacist's appropriate action?

Recommend reducing simvastatin dose to no more than 20 mg/day (Correct answer)
Discontinue amlodipine and use a different antihypertensive
Switch patient to rosuvastatin without prescriber notification
No action needed; the combination is safe

Correct answer: Recommend reducing simvastatin dose to no more than 20 mg/day

Amlodipine inhibits CYP3A4-mediated simvastatin metabolism; FDA recommends a simvastatin dose cap of 20 mg/day with amlodipine to reduce myopathy risk.

Question 69: How often should comprehensive medication reviews be conducted for high-risk patients?

Annually or as clinically indicated (Correct answer)
Once in a lifetime
Only when a patient requests
Every five years

Correct answer: Annually or as clinically indicated

For high-risk patients, such as those with multiple chronic conditions, polypharmacy, recent hospitalizations, or significant medication changes, comprehensive medication reviews should be conducted regularly. An annual review is generally recommended to reassess their medication regimen, but reviews should also occur more frequently if there are significant clinical changes or new medication-related problems arise. This proactive approach ensures ongoing medication safety and effectiveness, preventing potential issues.

Question 70: Which of the following best describes a key competency required for diabetes & cardiovascular pharmacotherapy in MTM practice?

The ability to work independently without any oversight
Reliance on a single methodology for all situations
Memorization of all relevant regulations without understanding context
Strong analytical skills combined with effective communication and ethical judgment (Correct answer)

Correct answer: Strong analytical skills combined with effective communication and ethical judgment

MTM professionals working in diabetes & cardiovascular pharmacotherapy need analytical skills to assess situations, communication skills to convey findings, and ethical judgment to make sound decisions.

Question 71: Which non-pharmacological intervention has the strongest evidence for chronic low back pain management as a first-line approach before initiating opioids?

Cognitive behavioral therapy and exercise (Correct answer)
Massage therapy alone
TENS (transcutaneous electrical nerve stimulation)
Acupuncture alone

Correct answer: Cognitive behavioral therapy and exercise

Cognitive behavioral therapy combined with exercise has the strongest evidence base for chronic low back pain and is recommended as first-line non-pharmacological treatment by multiple guidelines.

Question 72: How should pharmacists address language barriers with patients?

Speak louder and slower
Assume patients understand
Use interpreters or translated materials (Correct answer)
Avoid discussing sensitive topics

Correct answer: Use interpreters or translated materials

Language barriers can significantly impede effective communication and patient understanding of their medication regimen, potentially leading to serious errors. To ensure patient safety and comprehension, pharmacists must utilize professional medical interpreters or provide high-quality translated educational materials. Speaking louder or assuming understanding is ineffective and can compromise patient care and safety.

Question 73: Which proton pump inhibitor requires the LEAST concern for dose adjustment in severe renal impairment?

Pantoprazole
Lansoprazole
All PPIs require equal adjustment in renal failure (Correct answer)
Omeprazole

Correct answer: All PPIs require equal adjustment in renal failure

PPIs are primarily hepatically metabolized with minimal renal elimination, so none require dose adjustment for renal impairment.

Question 74: Which of the following statins carries the highest risk of myopathy due to drug interactions with CYP3A4 inhibitors?

Pravastatin
Fluvastatin
Rosuvastatin
Simvastatin (Correct answer)

Correct answer: Simvastatin

Simvastatin is extensively metabolized by CYP3A4, making it most susceptible to dose-dependent myopathy when combined with strong CYP3A4 inhibitors.

Question 75: In the context of MTM certification, what is the most important consideration when implementing specialty medication management?

Delegating all responsibilities to junior staff
Minimizing documentation to save time
Completing implementation as quickly as possible regardless of quality
Ensuring alignment with established standards, stakeholder needs, and best practices (Correct answer)

Correct answer: Ensuring alignment with established standards, stakeholder needs, and best practices

When implementing specialty medication management, MTM professionals must ensure alignment with industry standards and stakeholder needs. Hasty implementation without proper planning often leads to compliance issues and suboptimal outcomes.

Question 76: Roflumilast (Daliresp) is indicated as add-on therapy for which COPD patient population?

All COPD patients with FEV1 < 50% predicted
Severe COPD with chronic bronchitis phenotype and frequent exacerbations (Correct answer)
Asthma patients uncontrolled on ICS/LABA
COPD patients with predominantly emphysema phenotype

Correct answer: Severe COPD with chronic bronchitis phenotype and frequent exacerbations

Roflumilast, a PDE-4 inhibitor, is indicated for severe COPD patients with chronic bronchitis phenotype and ≥2 exacerbations per year despite standard therapy.

Question 77: A patient with heart failure is readmitted 10 days post-discharge. The pharmacist finds the patient stopped taking furosemide because the discharge instructions said 'water pill' but the prescription label said 'furosemide.' What type of barrier does this represent?

Provider prescribing error
Health literacy and communication gap (Correct answer)
Financial barrier to medication access
Formulary restriction

Correct answer: Health literacy and communication gap

Discrepancies between lay language and drug names cause confusion and non-adherence, highlighting health literacy communication gaps.

Question 78: In the context of care transitions, 'medication reconciliation' is BEST defined as:

The process of comparing a patient's medication orders to all medications the patient has been taking to avoid errors (Correct answer)
Switching brand-name drugs to generic equivalents at discharge
Adjusting medication doses based on the patient's insurance formulary
Counting pills to verify a patient's supply matches their prescription

Correct answer: The process of comparing a patient's medication orders to all medications the patient has been taking to avoid errors

Medication reconciliation is the formal process of comparing ordered medications against the patient's complete medication list to identify and resolve discrepancies.

Question 79: A patient on warfarin has an INR of 4.8 with no signs of bleeding. What is the most appropriate clinical action?

Continue current dose and recheck in 1 week
Discontinue warfarin permanently
Administer vitamin K 10 mg IV immediately
Hold 1-2 doses and recheck INR in 1-2 days (Correct answer)

Correct answer: Hold 1-2 doses and recheck INR in 1-2 days

For supratherapeutic INR (4.5-10) without bleeding, holding 1-2 doses and rechecking INR in 24-48 hours is the standard approach.

Question 80: Which factor most affects the pharmacokinetics of a drug?

Gender only.
Brand of medication.
Patient-specific factors like age and renal function (Correct answer)
Color of the medication.

Correct answer: Patient-specific factors like age and renal function

Pharmacokinetics describes how the body processes a drug, including its absorption, distribution, metabolism, and excretion. Patient-specific factors such as age, renal function, liver function, and genetic makeup significantly influence these processes. These individual differences dictate how a drug is handled by the body, directly affecting its concentration, duration of action, and overall effectiveness or potential for toxicity.

Question 81: During an MTM session, a patient says, 'I don't really understand why I need to take all these medications.' What is the pharmacist's BEST response?

Explore the patient's understanding and collaboratively explain each medication's purpose (Correct answer)
Provide a written medication list and end the consultation
Reduce the medication list immediately to improve adherence
Tell the patient their doctor prescribed them for good reasons

Correct answer: Explore the patient's understanding and collaboratively explain each medication's purpose

Exploring the patient's understanding first and then providing tailored education promotes engagement and improves adherence.

Question 82: Which patient population benefits most from CMRs?

Patients with polypharmacy and chronic conditions (Correct answer)
Single-medication users
Young, healthy adults
Occasional supplement users

Correct answer: Patients with polypharmacy and chronic conditions

Patients taking multiple medications (polypharmacy) and those managing several chronic conditions are at a significantly higher risk for medication-related problems, including drug interactions, adverse effects, and non-adherence. Comprehensive Medication Reviews (CMRs) are particularly beneficial for this population as they help streamline complex regimens, identify potential issues, and optimize therapy to improve health outcomes and safety, reducing their risk of harm.

Question 83: In monitoring a patient on methotrexate for rheumatoid arthritis, which laboratory finding most directly signals hepatotoxicity?

Platelet count <100,000/mm³
AST/ALT >3× upper limit of normal on two consecutive tests (Correct answer)
Low serum albumin <3.5 g/dL
Elevated serum creatinine

Correct answer: AST/ALT >3× upper limit of normal on two consecutive tests

Persistently elevated transaminases (>3× ULN on two tests 4-6 weeks apart) are the primary signal for methotrexate hepatotoxicity requiring dose reduction or discontinuation.

Question 84: In MTM documentation, the term 'drug therapy problem (DTP)' is most accurately defined as:

An undesirable event experienced by a patient that involves drug therapy and actually or potentially interferes with achieving the goals of therapy (Correct answer)
Any adverse drug event requiring emergency department treatment
A formulary exception request submitted to a Part D plan
A medication error caught during the dispensing process

Correct answer: An undesirable event experienced by a patient that involves drug therapy and actually or potentially interferes with achieving the goals of therapy

A DTP is defined as any undesirable event involving drug therapy that interferes or potentially interferes with desired patient outcomes, as established by Cipolle, Strand, and Morley.

Question 85: A patient with T2DM and heart failure with reduced ejection fraction (HFrEF) is on an SGLT2 inhibitor. Which additional medication class has been shown to reduce mortality in HFrEF?

DPP-4 inhibitors
Sulfonylureas
Sacubitril/valsartan (ARNI) (Correct answer)
Pioglitazone

Correct answer: Sacubitril/valsartan (ARNI)

Sacubitril/valsartan is a guideline-directed therapy for HFrEF that reduces mortality and is appropriate alongside SGLT2 inhibitors.

Question 86: An MTM pharmacist is counseling a patient on valproate for bipolar disorder who is considering pregnancy. What is the most critical concern?

Valproate is the safest mood stabilizer in pregnancy
Valproate is a known teratogen causing neural tube defects and cognitive impairment (Correct answer)
Valproate must be stopped 6 months before conception
Valproate decreases folate absorption only

Correct answer: Valproate is a known teratogen causing neural tube defects and cognitive impairment

Valproate is a category X teratogen associated with neural tube defects (spina bifida), cognitive impairment, and autism spectrum disorder; alternative mood stabilizers should be considered in reproductive-age women.

Question 87: Which federal regulation primarily governs privacy in pharmacy records?

HIPAA (Correct answer)
DEA.
FDA.
OSHA.

Correct answer: HIPAA

The Health Insurance Portability and Accountability Act (HIPAA) is the federal regulation that primarily governs the privacy and security of patient health information. It sets national standards for how pharmacists and other healthcare providers must protect sensitive medical records, ensuring confidentiality and preventing unauthorized disclosure.

Question 88: The 'Ask Me 3' program encourages patients to ask their healthcare providers three key questions. Which question is INCLUDED in Ask Me 3?

'What is the generic name of my medication?'
'What is my main problem?' (Correct answer)
'Which insurance plan covers this medication?'
'How many refills am I allowed?'

Correct answer: 'What is my main problem?'

Ask Me 3 prompts patients to ask: What is my main problem? What do I need to do? Why is it important for me to do this?

Question 89: Which principle guides the deprescribing process in polypharmacy management?

Tapering or discontinuing one medication at a time to monitor for withdrawal or disease recurrence (Correct answer)
Replacing multiple medications with a single combination product
Stopping all inappropriate medications simultaneously for efficiency
Deferring deprescribing decisions to the prescribing physician only

Correct answer: Tapering or discontinuing one medication at a time to monitor for withdrawal or disease recurrence

Discontinuing one medication at a time allows for monitoring of withdrawal effects and disease recurrence attributable to each specific medication.

Question 90: What is a red flag in drug therapy monitoring?

High drug cost.
Clear urine.
Low prescription volume.
Symptoms of toxicity or lack of therapeutic effect (Correct answer)

Correct answer: Symptoms of toxicity or lack of therapeutic effect

A 'red flag' in drug therapy monitoring refers to any sign or symptom that indicates a potential problem with the medication regimen. This includes the manifestation of adverse drug reactions, which are symptoms of toxicity, or the absence of the expected beneficial outcome, indicating a lack of therapeutic effect. Both scenarios warrant immediate investigation and potential adjustment of the therapy to ensure patient safety and efficacy.

Question 91: What is the PRIMARY goal of a Comprehensive Medication Review (CMR) in the context of polypharmacy?

Ensure patient adherence to all prescribed medications
Generate a complete list of medications for the patient's chart
Reduce medication costs for the insurance payer
Identify, resolve, and prevent medication-related problems to optimize therapeutic outcomes (Correct answer)

Correct answer: Identify, resolve, and prevent medication-related problems to optimize therapeutic outcomes

The CMR systematically identifies medication-related problems including inappropriateness, interactions, and duplications to optimize therapy and improve patient outcomes.

Question 92: Which electrolyte abnormality is most commonly associated with progressive CKD and affects drug therapy choices?

Hyperkalemia (Correct answer)
Hypocalcemia
Hyponatremia
Hypomagnesemia

Correct answer: Hyperkalemia

Hyperkalemia is common in CKD and restricts use of drugs that increase potassium, such as ACE inhibitors, ARBs, and potassium-sparing diuretics.

Question 93: Which element is REQUIRED in the CMR written summary according to CMS MTM program guidelines?

A list of the patient's insurance premiums
The prescribing physician's DEA number
A prioritized list of medication-related action items for the patient (Correct answer)
Recommended laboratory tests ordered by the pharmacist

Correct answer: A prioritized list of medication-related action items for the patient

CMS requires the CMR written summary to include a prioritized list of medication-related action items, along with the PML and follow-up schedule.

Question 94: Which anticoagulant is preferred for the treatment of cancer-associated thrombosis based on current guidelines?

Warfarin with target INR 2.5–3.5
Low molecular weight heparin or edoxaban/rivaroxaban (DOACs) (Correct answer)
Fondaparinux subcutaneously for 6 months
Unfractionated heparin infusion for the duration of chemotherapy

Correct answer: Low molecular weight heparin or edoxaban/rivaroxaban (DOACs)

LMWH has historically been preferred for cancer-associated thrombosis, but DOACs (edoxaban, rivaroxaban) are now guideline-endorsed alternatives except in patients with GI malignancies at high bleeding risk.

Question 95: What is the significance of the half-life of a drug?

It shows the strength of the medication.
It identifies the side effects.
It indicates the manufacturer.
It determines how often the drug is taken (Correct answer)

Correct answer: It determines how often the drug is taken

The half-life of a drug is the time it takes for the concentration of the drug in the body to be reduced by half. This pharmacokinetic parameter is fundamental in determining the appropriate dosing interval and frequency for a medication. A drug with a short half-life typically requires more frequent dosing to maintain therapeutic levels, while a drug with a long half-life can be given less often.

Question 96: What is the primary role of a Risk Evaluation and Mitigation Strategy (REMS) for extended-release/long-acting (ER/LA) opioids?

To ensure prescribers, pharmacists, and patients understand serious risks and safe use (Correct answer)
To replace state PDMPs as the sole monitoring tool
To mandate urine drug screening at every patient visit
To restrict opioid prescribing exclusively to pain management specialists

Correct answer: To ensure prescribers, pharmacists, and patients understand serious risks and safe use

The ER/LA Opioid Analgesics REMS requires prescriber education, patient counseling via Medication Guides, and emphasizes appropriate patient selection to mitigate risks of misuse, abuse, addiction, overdose, and death.

Question 97: Which federal regulation requires MTM programs to be offered to beneficiaries who meet specific criteria related to chronic disease burden and medication use?

The Omnibus Budget Reconciliation Act (OBRA) of 1990
The Medicare Modernization Act (MMA) of 2003 (Correct answer)
The Drug Enforcement Administration (DEA) Practitioner's Manual
The Health Information Technology for Economic and Clinical Health (HITECH) Act

Correct answer: The Medicare Modernization Act (MMA) of 2003

The Medicare Modernization Act of 2003 established the Part D MTM program requirement, including eligibility criteria based on multiple chronic conditions, multiple medications, and likelihood of high drug costs.

Question 98: What is the best practice when documenting a patient encounter?

Delay documentation until end of week.
Include only billing information.
Only document medication changes.
Document all relevant details promptly and accurately (Correct answer)

Correct answer: Document all relevant details promptly and accurately

Documenting all relevant details promptly and accurately is the best practice because it ensures continuity of care and facilitates effective communication among healthcare providers. Timely and precise records are crucial for legal compliance, patient safety, and making informed decisions, preventing misunderstandings or errors that could arise from delayed or incomplete information.

Question 99: A frail 85-year-old patient with moderate dementia is taking a cholinesterase inhibitor, memantine, and antipsychotic. Which consideration is MOST relevant for the MTM pharmacist?

All three medications should be continued indefinitely for dementia management
Cholinesterase inhibitors are contraindicated in patients over 80
Antipsychotics carry an FDA black box warning for increased mortality in elderly patients with dementia-related psychosis (Correct answer)
Memantine should be discontinued when antipsychotics are added

Correct answer: Antipsychotics carry an FDA black box warning for increased mortality in elderly patients with dementia-related psychosis

The FDA requires a black box warning on antipsychotics regarding increased risk of death in elderly patients with dementia-related psychosis, making their use a high-priority deprescribing candidate.

Question 100: When monitoring a patient on clozapine, which laboratory value requires the MOST stringent surveillance schedule due to a potentially fatal adverse effect?

Fasting glucose (monthly for 3 months, then quarterly)
Serum clozapine level (every 6 months)
QTc interval (baseline and after each dose increase)
Absolute neutrophil count (ANC) per REMS protocol (Correct answer)

Correct answer: Absolute neutrophil count (ANC) per REMS protocol

Clozapine's REMS program mandates ANC monitoring to detect clozapine-induced agranulocytosis, a potentially fatal adverse effect requiring immediate drug discontinuation if ANC falls below threshold.

APhA Medication Therapy Management (MTM) Certification Exam

This certification validates a pharmacist's ability to provide comprehensive medication therapy management services to optimize patient outcomes.

100

Questions

120 min

Time Limit

70%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds